Truace
Subscribe

Machine learning and multi-omics technologies for precision cardiovascular medicine: advancing diagnosis, risk prediction, and therapeutic guidance

Cardiovascular disease remains a major global health burden. Owing to its complex pathogenesis and marked clinical heterogeneity, conventional one-size-fits-all strategies often yield limited benefit for a substantial proportion of patients. Precision medicine advocates individualized management based on patients' clinical and molecular characteristics to improve outcomes. In this context, multi-omics and machine learning provide critical technical support for precision medicine: multi-omics can capture the full…

By the Truvace desk1 min read1 sourcePeer-reviewedTRV-2026-0784· cite & verify
Machine learning and multi-omics technologies for precision cardiovascular medicine: advancing diagnosis, risk prediction, and therapeutic guidance
Hospital Universitari Doctor Peset, València 05 by 19Tarrestnom65. CC BY-SA 4.0 · https://creativecommons.org/licenses/by-sa/4.0

In brief

Published August 13, 2026 as a peer-reviewed review in Frontiers in Cardiovascular Medicine, the article synthesizes recent advances using machine learning together with multi-omics to address cardiovascular disease heterogeneity where conventional one-size-fits-all strategies often yield limited benefit.

The synthesis matters because it links technical capabilities to clinical tasks like noninvasive diagnosis and full-course risk management and individualized treatment prediction, while uncertainty remains about how to ensure data quality, ongoing validation, transparency, accountability, and policy support for cost coverage and implementation.

Main points

  1. Review focuses on three core domains: diagnosis, risk prediction, and treatment response prediction for cardiovascular disease.
  2. Multi-omics captures spectrum from molecular alterations to phenotypic manifestations while machine learning models high-dimensional nonlinear associations with clinical outcomes.
  3. In risk prediction, approaches support primary prevention, secondary prevention, short-term risk stratification, and screening of high-risk populations.
  4. Authors note precision medicine aims to replace one-size-fits-all strategies that often yield limited benefit due to clinical heterogeneity.

The gain

Integration of multi-omics and machine learning can improve cardiovascular disease management by supporting definitive and early diagnosis, severity assessment, full-course risk stratification, and individualized prediction of drug and surgical benefit-risk to inform decisions.

The rundown

The review describes multi-omics as capturing the full spectrum from molecular alterations to phenotypic manifestations, paired with machine learning suited to high-dimensional nonlinear data, applied to diagnosis for definitive, early, differential and severity assessment.

For risk prediction it outlines a framework spanning primary and secondary prevention, short-term stratification and high-risk screening, and for therapy it discusses individualized prediction of pharmacological and surgical benefits and risks to inform decision-making.

Sources

  1. Peer-reviewedFrontiers in Cardiovascular Medicine2026-08-13

The debate